-
MAPS Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here
Monday, December 9, 2024 - 7:21pm | 621The Multidisciplinary Association for Psychedelic Studies (MAPS) introduced "Music is the Bridge," a new campaign that combines artist-curated playlists with free psychedelic education. Starting Monday, the project aims to make psychedelic experiences safer, more accessible and more meaningful....
-
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
Thursday, September 5, 2024 - 5:31pm | 535Amy Emerson, the CEO of Lykos Therapeutics, has stepped down from her role at the company, the WSJ reported. This announcement comes nearly a month after the Food and Drug Administration (FDA) rejected Lykos’s application for its ecstasy-based therapy intended to treat post-traumatic stress...
-
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
Friday, August 16, 2024 - 12:25pm | 510Lykos Therapeutics has announced a strategic reorganization in response to the recent FDA decision regarding its new drug application for MDMA capsules – also known as Ecstasy or Molly – intended for treating post-traumatic stress disorder (PTSD) in adults. New Senior Medical Advisor As...
-
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
Tuesday, August 13, 2024 - 4:53pm | 700In a significant development in the field of psychedelic medicine, the journal Psychopharmacology has retracted three research papers on MDMA-assisted therapy due to what it described as unethical conduct at one of the study sites. As New York Times reported, the retraction has cast a shadow over...
-
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
Friday, August 9, 2024 - 5:14pm | 893The U.S. Food and Drug Administration (FDA) is on the verge of making a historic decision regarding the approval of Lykos Therapeutics MDMA-assisted therapy as a mainstream medical treatment for post-traumatic stress disorder (PTSD). The decision, expected by August 11, could mark a turning point...
-
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
Wednesday, August 7, 2024 - 7:52pm | 718The potential of MDMA-assisted therapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) has garnered significant attention, including many scientific studies that indicate promising results. However, while the majority of the results suggest safety and efficacy, researchers emphasize...
-
Denver To Become First US City To Train First Responders In Psychedelics Crisis Intervention
Monday, March 11, 2024 - 7:52pm | 518The nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) is partnering with the City and County of Denver, Colorado to provide comprehensive training on psychedelic crisis assessment and intervention to the city's first responders. The Psychedelic Crisis Assessment and...
-
Is Ibogaine A Safe And Effective Treatment For Addictions?
Thursday, August 25, 2022 - 12:40pm | 2494By Santiago Federico Richetti via El Planteo. The consumption of substances of different types is inherent to human beings. Throughout history, individuals belonging to different cultures, societies, and civilizations have sought pleasurable sensations or comfort through them. The use of drugs does...